AngioDynamics Inc.

9.30
0.06 (0.65%)
At close: Apr 11, 2025, 3:59 PM
9.25
-0.54%
After-hours: Apr 11, 2025, 05:42 PM EDT
0.65%
Bid 9
Market Cap 377.65M
Revenue (ttm) 283.32M
Net Income (ttm) -41.39M
EPS (ttm) -1.01
PE Ratio (ttm) -9.21
Forward PE -58.64
Analyst Strong Buy
Ask 10.8
Volume 228,200
Avg. Volume (20D) 655,564
Open 9.20
Previous Close 9.24
Day's Range 9.03 - 9.43
52-Week Range 5.47 - 13.50
Beta 0.52

About ANGO

AngioDynamics, Inc. designs, manufactures, and sells various medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and vascular access; and for use in oncology and surgical settings in the United States and internationally. The company provides NanoKnife ablation systems for the surgical ablation of soft tissues; solero microwave tissue ablation systems; and radiofrequ...

Sector Healthcare
IPO Date Jun 1, 2004
Employees 748
Stock Exchange NASDAQ
Ticker Symbol ANGO
Full Company Profile

Analyst Forecast

According to 2 analyst ratings, the average rating for ANGO stock is "Strong Buy." The 12-month stock price forecast is $14, which is an increase of 50.54% from the latest price.

Stock Forecasts

Earnings Surprise

AngioDynamics has released their quartely earnings on Apr 2, 2025:
  • Revenue of $72M exceeds estimates by $1.7M, with -4.23% YoY decline.
  • EPS of -0.08 exceeds estimates by 0.05, with 50.00% YoY growth.
  • Next Earnings Release

    AngioDynamics Inc. is scheduled to release its earnings on Jul 15, 2025, before market opens.
    Analysts project revenue of ... Unlock content with Pro Subscription
    1 week ago
    +12.42%
    AngioDynamics shares are trading higher after the ... Unlock content with Pro Subscription
    3 months ago
    +37.66%
    AngioDynamics shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY25 adjusted EPS guidance.